[Quantitative properties of a new cardiac glycoside].
D000284:Administration, Oral; D000368:Aged; D004077:Digoxin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D005069:Evaluation Studies as Topic; D005080:Exercise Test; D006333:Heart Failure / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D007275:Injections, Intravenous; D007408:Intestinal Absorption; D008297:Male; D008745:Methylation; D008875:Middle Aged; D013997:Time Factors; D014690:Venous Pressure / Q000187:drug effects
D004077:Digoxin
Quantitative Eigenschaften eines neuen Herzglykosids.